Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies
Antigen-binding fragments of antibodies specific to the tumor-associated ganglioside GD2 are well poised to play a substantial role in modern GD2-targeted cancer therapies, however, rapid elimination from the body and reduced affinity compared to full-length antibodies limit their therapeutic potent...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/21/3835 |
id |
doaj-63d260e83a8b4c54842c491d2f1b4b63 |
---|---|
record_format |
Article |
spelling |
doaj-63d260e83a8b4c54842c491d2f1b4b632020-11-25T01:56:34ZengMDPI AGMolecules1420-30492019-10-012421383510.3390/molecules24213835molecules24213835Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific AntibodiesIrina V. Kholodenko0Daniel V. Kalinovsky1Elena V. Svirshchevskaya2Igor I. Doronin3Maria V. Konovalova4Alexey V. Kibardin5Tatyana V. Shamanskaya6Sergey S. Larin7Sergey M. Deyev8Roman V. Kholodenko9Orekhovich Institute of Biomedical Chemistry, 10, Pogodinskaya St., Moscow 119121, RussiaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10, Miklukho-Maklaya St., Moscow 117997, RussiaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10, Miklukho-Maklaya St., Moscow 117997, RussiaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10, Miklukho-Maklaya St., Moscow 117997, RussiaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10, Miklukho-Maklaya St., Moscow 117997, RussiaD. Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology, 1, Samory Mashela St., Moscow 117997, RussiaD. Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology, 1, Samory Mashela St., Moscow 117997, RussiaD. Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology, 1, Samory Mashela St., Moscow 117997, RussiaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10, Miklukho-Maklaya St., Moscow 117997, RussiaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10, Miklukho-Maklaya St., Moscow 117997, RussiaAntigen-binding fragments of antibodies specific to the tumor-associated ganglioside GD2 are well poised to play a substantial role in modern GD2-targeted cancer therapies, however, rapid elimination from the body and reduced affinity compared to full-length antibodies limit their therapeutic potential. In this study, scFv fragments of GD2-specific antibodies 14.18 were produced in a mammalian expression system that specifically bind to ganglioside GD2, followed by site-directed pegylation to generate mono-, di-, and tetra-scFv fragments. Fractionated pegylated dimers and tetramers of scFv fragments showed significant increase of the binding to GD2 which was not accompanied by cross-reactivity with other gangliosides. Pegylated multimeric di-scFvs and tetra-scFvs exhibited cytotoxic effects in GD2-positive tumor cells, while their circulation time in blood significantly increased compared with monomeric antibody fragments. We also demonstrated a more efficient tumor uptake of the multimers in a syngeneic GD2-positive mouse cancer model. The findings of this study provide the rationale for improving therapeutic characteristics of GD2-specific antibody fragments by multimerization and propose a strategy to generate such molecules. On the basis of multimeric antibody fragments, bispecific antibodies and conjugates with cytotoxic drugs or radioactive isotopes may be developed that will possess improved pharmacokinetic and pharmacodynamic properties.https://www.mdpi.com/1420-3049/24/21/3835antibody fragmentspegylationmultimerizationganglioside gd2immunotherapycancerneuroblastoma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Irina V. Kholodenko Daniel V. Kalinovsky Elena V. Svirshchevskaya Igor I. Doronin Maria V. Konovalova Alexey V. Kibardin Tatyana V. Shamanskaya Sergey S. Larin Sergey M. Deyev Roman V. Kholodenko |
spellingShingle |
Irina V. Kholodenko Daniel V. Kalinovsky Elena V. Svirshchevskaya Igor I. Doronin Maria V. Konovalova Alexey V. Kibardin Tatyana V. Shamanskaya Sergey S. Larin Sergey M. Deyev Roman V. Kholodenko Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies Molecules antibody fragments pegylation multimerization ganglioside gd2 immunotherapy cancer neuroblastoma |
author_facet |
Irina V. Kholodenko Daniel V. Kalinovsky Elena V. Svirshchevskaya Igor I. Doronin Maria V. Konovalova Alexey V. Kibardin Tatyana V. Shamanskaya Sergey S. Larin Sergey M. Deyev Roman V. Kholodenko |
author_sort |
Irina V. Kholodenko |
title |
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies |
title_short |
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies |
title_full |
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies |
title_fullStr |
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies |
title_full_unstemmed |
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies |
title_sort |
multimerization through pegylation improves pharmacokinetic properties of scfv fragments of gd2-specific antibodies |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2019-10-01 |
description |
Antigen-binding fragments of antibodies specific to the tumor-associated ganglioside GD2 are well poised to play a substantial role in modern GD2-targeted cancer therapies, however, rapid elimination from the body and reduced affinity compared to full-length antibodies limit their therapeutic potential. In this study, scFv fragments of GD2-specific antibodies 14.18 were produced in a mammalian expression system that specifically bind to ganglioside GD2, followed by site-directed pegylation to generate mono-, di-, and tetra-scFv fragments. Fractionated pegylated dimers and tetramers of scFv fragments showed significant increase of the binding to GD2 which was not accompanied by cross-reactivity with other gangliosides. Pegylated multimeric di-scFvs and tetra-scFvs exhibited cytotoxic effects in GD2-positive tumor cells, while their circulation time in blood significantly increased compared with monomeric antibody fragments. We also demonstrated a more efficient tumor uptake of the multimers in a syngeneic GD2-positive mouse cancer model. The findings of this study provide the rationale for improving therapeutic characteristics of GD2-specific antibody fragments by multimerization and propose a strategy to generate such molecules. On the basis of multimeric antibody fragments, bispecific antibodies and conjugates with cytotoxic drugs or radioactive isotopes may be developed that will possess improved pharmacokinetic and pharmacodynamic properties. |
topic |
antibody fragments pegylation multimerization ganglioside gd2 immunotherapy cancer neuroblastoma |
url |
https://www.mdpi.com/1420-3049/24/21/3835 |
work_keys_str_mv |
AT irinavkholodenko multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT danielvkalinovsky multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT elenavsvirshchevskaya multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT igoridoronin multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT mariavkonovalova multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT alexeyvkibardin multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT tatyanavshamanskaya multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT sergeyslarin multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT sergeymdeyev multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies AT romanvkholodenko multimerizationthroughpegylationimprovespharmacokineticpropertiesofscfvfragmentsofgd2specificantibodies |
_version_ |
1724979261397270528 |